🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 21 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
30/05/1989 0,0652 USD
02/03/1989 0,0652 USD
29/11/1988 0,0588 USD
29/08/1988 0,0469 USD
03/06/1988 0,0509 USD
29/02/1988 0,0509 USD
01/12/1987 0,0424 USD
28/08/1987 0,0424 USD
02/06/1987 0,0292 USD
02/03/1987 0,0292 USD
02/12/1986 0,0292 USD
02/09/1986 0,0292 USD
03/06/1986 0,0239 USD
27/02/1986 0,0239 USD
03/12/1985 0,0239 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/08/2025 87,50 87,84 86,76 87,37 +1,50% 1,23% 11.977.400
21/08/2025 84,88 87,32 84,60 86,08 +1,68% 3,20% 13.889.000
20/08/2025 85,31 86,25 84,55 84,66 -0,32% 1,99% 8.904.700
19/08/2025 84,38 85,80 84,38 84,93 +0,84% 1,68% 14.307.700
18/08/2025 84,26 85,15 84,08 84,22 +0,01% 1,27% 8.273.600
15/08/2025 83,72 84,74 83,36 84,21 +1,75% 1,65% 10.481.400
14/08/2025 82,01 83,40 81,60 82,76 +0,06% 2,19% 10.217.600
13/08/2025 80,75 82,84 80,20 82,71 +3,00% 3,27% 11.043.800
12/08/2025 80,47 80,94 79,67 80,30 +0,34% 1,58% 7.852.700
11/08/2025 80,96 81,64 79,63 80,03 -0,82% 2,48% 8.210.700
08/08/2025 80,11 81,17 80,11 80,69 +0,40% 1,32% 6.882.900
07/08/2025 79,65 80,82 78,65 80,37 +1,17% 2,72% 10.830.100
06/08/2025 80,29 81,32 79,27 79,44 -1,67% 2,55% 13.028.700
05/08/2025 79,90 81,13 79,57 80,79 +1,16% 1,95% 9.984.300
04/08/2025 79,06 79,99 78,43 79,86 +0,72% 1,97% 13.380.700
01/08/2025 78,02 79,87 77,53 79,29 +1,50% 3,00% 11.900.300
31/07/2025 80,80 81,49 77,85 78,12 -4,44% 4,50% 19.813.300
30/07/2025 82,91 83,58 81,52 81,75 -1,06% 2,48% 13.055.200
29/07/2025 79,85 82,89 76,66 82,63 -1,70% 7,80% 27.826.400
28/07/2025 84,47 84,97 83,87 84,06 -0,77% 1,30% 12.882.000
25/07/2025 84,16 85,22 83,84 84,71 +0,71% 1,64% 10.058.800
24/07/2025 84,20 84,51 83,52 84,11 +0,15% 1,18% 8.016.700
23/07/2025 82,62 84,14 82,41 83,98 +2,90% 2,09% 11.542.100
22/07/2025 79,87 81,77 79,87 81,61 +2,90% 2,38% 10.571.000
21/07/2025 80,16 80,31 78,95 79,31 -0,81% 1,70% 11.620.800
18/07/2025 81,70 81,92 79,86 79,96 -1,91% 2,52% 11.823.600
17/07/2025 81,98 82,66 81,34 81,52 -1,10% 1,61% 8.984.800
16/07/2025 81,46 82,64 81,46 82,43 +1,12% 1,45% 11.517.800
15/07/2025 83,78 84,36 81,30 81,52 -2,57% 3,65% 10.827.000
14/07/2025 83,43 84,30 83,11 83,67 +0,37% 1,43% 10.368.700